Suzetrigine: Is This What We Have Been Waiting for or Just the Beginning?

Abstract

Christopher L Robinson,1 Michael E Schatman,2,3 Jamal Hasoon,4 Matthew Chung,5 Trent Emerick,6 Giuliano Lo Bianco,7 Sait Ashina,8,9,* R Jason Yong1,* 1Department of Anesthesiology, Perioperative and Pain Medicine, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA; 2Department of Anesthesiology, Perioperative Care and Pain Medicine, NYU Grossman School of Medicine, New York, NY, USA; 3Department of Population Health - Division of Medical Ethics, NYU Grossman School of Medicine, New York, NY, USA; 4Department of Anesthesia, Critical Care, and Pain Medicine, UTHealth, McGovern Medical School, Houston, TX, USA; 5Department of Pain Medicine, Division of Anesthesia, Critical Care and Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 6Department of Anesthesiology and Perioperative Medicine, Chronic Pain Division, University of Pittsburgh Medical Center, Pittsburgh, PA, USA; 7Anesthesiology and Pain Department, Foundation G. Giglio Cefalù, Palermo, Italy; 8Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; 9Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA*These authors contributed equally to this workCorrespondence: Christopher L Robinson, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, 75 Francis St, Boston, MA, 02118, USA, Email [email protected]